While doctors believe industry funding may bias their continuing medical education, they are unwilling to pay for impartial information, a new survey finds. Reuters Health Information
Category: News
Study Identifies Glaucoma Progression Risk Factors
Peak intraocular pressure, corneal thinning, and retinal atrophy emerge as major risks in a “real-world” study. Medscape Medical News
Why Physician Compensation Plans Fail
Physicians often consider their group’s compensation plan as unfair, particularly if the income-sharing and expense-sharing formula favors some doctors over others. Here’s what to watch out for. Medscape Business of Medicine
Kowa Announces The Efficacy And Safety Of A Novel Rho Kinase Inhibitor (K-115) In The Treatment Of Glaucoma In ARVO 2011
Kowa Company Ltd, (Headquarters: Nagoya, Japan, President & CEO: Yoshihiro Miwa, “Kowa”) today announced the results of two clinical studies and a non-clinical study of a drug candidate for glaucoma and ocular hypertension (K-115). The results were pre…
Kowa Announces The Efficacy And Safety Of A Novel Rho Kinase Inhibitor (K-115) In The Treatment Of Glaucoma In ARVO 2011
Kowa Company Ltd, (Headquarters: Nagoya, Japan, President & CEO: Yoshihiro Miwa, “Kowa”) today announced the results of two clinical studies and a non-clinical study of a drug candidate for glaucoma and ocular hypertension (K-115). The results were pre…
Single Bioptic Telescope For Low Vision Driving May Not Obscure Road View Of Second Eye
A study by scientists at Schepens Eye Research Institute shows that a bioptic telescope on one lens of a pair of glasses used to magnify traffic signs and lights may not prevent the wider view of the road with the second eye…
Single Bioptic Telescope For Low Vision Driving May Not Obscure Road View Of Second Eye
A study by scientists at Schepens Eye Research Institute shows that a bioptic telescope on one lens of a pair of glasses used to magnify traffic signs and lights may not prevent the wider view of the road with the second eye…
Inspire reports net loss of $17.6 million for first quarter 2011
Inspire Pharmaceuticals, Inc. announced today financial results for the first quarter ended March 31, 2011, reporting a net loss of $17.6 million or per common share, as compared to a net loss of $14.8 million, or per common share, for the same period …
Mary Ann Liebert’s peer-reviewed journal highlights latest developments in ocular gene therapy
Disorders of the eye are excellent targets for gene therapy because the ocular environment is readily accessible, relatively easy to monitor, and sequestered from the rest of the body.
Latest Advances In Gene Therapy For Ocular Disease Are Highlighted In Human Gene Therapy
Disorders of the eye are excellent targets for gene therapy because the ocular environment is readily accessible, relatively easy to monitor, and sequestered from the rest of the body. A series of articles available online ahead of print in Human Gene …
Kowa presents three K-115 study results against glaucoma at ARVO 2011
Kowa Company Ltd, today announced the results of two clinical studies and a non-clinical study of a drug candidate for glaucoma and ocular hypertension.
Careful Management Needed For Intraocular Foreign Bodies
An intraocular foreign body is an unwanted presence in the eye. The size, shape, direction and velocity of impact of the foreign body, as well as its path through the eye, affect the final outcome. The U.S. National Eye Trauma Registry shows that there…
Careful Management Needed For Intraocular Foreign Bodies
An intraocular foreign body is an unwanted presence in the eye. The size, shape, direction and velocity of impact of the foreign body, as well as its path through the eye, affect the final outcome. The U.S. National Eye Trauma Registry shows that there…
Study Identifies Glaucoma Progression Risk Factors
Peak intraocular pressure, corneal thinning, and retinal atrophy are among the significant risk factors for visual field deterioration in patients with glaucoma, according to a new study published in the May issue of the Archives of Ophthalmology.
Study Evaluates Cost-Effectiveness Of Strategies To Treat Infant Tear-Duct Obstruction
When infants’ tear ducts are blocked, the decision about when to intervene and the cost-effectiveness of doing so depend on how likely it is the problem will self-resolve, according to a report in the May issue of Archives of Ophthalmology, one of the …
Research Identifies Risk Factors Associated With Progression Of Glaucoma
Elevated pressure inside the eye, cornea thinning, and visual field loss are all markers that glaucoma may progress, according to a report in the May issue of Archives of Ophthalmology, one of the JAMA/Archives journals. Glaucoma is one of the world…
Research Identifies Risk Factors Associated With Progression Of Glaucoma
Elevated pressure inside the eye, cornea thinning, and visual field loss are all markers that glaucoma may progress, according to a report in the May issue of Archives of Ophthalmology, one of the JAMA/Archives journals. Glaucoma is one of the world…
Study Evaluates Cost-Effectiveness Of Strategies To Treat Infant Tear-Duct Obstruction
When infants’ tear ducts are blocked, the decision about when to intervene and the cost-effectiveness of doing so depend on how likely it is the problem will self-resolve, according to a report in the May issue of Archives of Ophthalmology, one of the …
Artificial Retina Lets There Be Light, Object Discrimination
All patients who received a retinal prosthesis can see light, and some can identify basic objects in their environment. Medscape Medical News
Defending Yourself Against Pain and Suffering Lawsuits
Pain, suffering, mental distress, and other non-economic damages often comprise a major portion of the financial award to an injured patient. Here’s what juries look at. Medscape Business of Medicine